Ligand- and Protein-Based Modeling Studies of the Inhibitors of Human Cytochrome P450 2D6 and a Virtual Screening for Potential Inhibitors from the Chinese Herbal Medicine, Scutellaria baicalensis (Huangqin, Baikal Skullcap)

被引:22
作者
Mo, Sui-Lin [2 ,3 ]
Liu, Wei-Feng
Chen, Yuling [4 ,5 ]
Luo, Hai-Bin [6 ]
Sun, Lai-Bao [7 ]
Chen, Xiao-Wu [8 ]
Zhou, Zhi-Wei [2 ,3 ]
Sneed, Kevin B. [9 ]
Li, Chun Guang [2 ,3 ]
Du, Yao-Min [10 ]
Liang, Jun [1 ]
Zhou, Shu-Feng [1 ,2 ,3 ]
机构
[1] Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33612 USA
[2] RMIT Univ, Sch Hlth Sci, Bundoora, Vic 3083, Australia
[3] RMIT Univ, Hlth Innovat Res Inst, Bundoora, Vic 3083, Australia
[4] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia
[5] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[6] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China
[7] Sun Yat Sen Univ, Dept Anesthesiol, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China
[8] So Med Univ, Dept Gen Surg, Shunde Peoples Hosp 1, Foshan, Guangdong, Peoples R China
[9] Univ S Florida, Dept Pharmacotherapeut & Clin Res, Coll Pharm, Tampa, FL 33612 USA
[10] Guangdong Prov Peoples Hosp, Dept Med, Guangzhou, Guangdong, Peoples R China
关键词
Chinese herbal medicine; CYP2D6; inhibitor; molecular docking; pharmacophore; QSAR; virtual screening; HUMAN LIVER-MICROSOMES; ANTIPSYCHOTIC AGENT OLANZAPINE; SEROTONIN REUPTAKE INHIBITORS; INTERACTIONS IN-VIVO; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; DRUG-INTERACTIONS; PREDICTIVE METABOLISM; MOLECULAR DOCKING; VITRO INHIBITION;
D O I
10.2174/138620712798280826
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
We have previously examined the binding patterns of various substrates to human cytochrome P450 2D6 (CYP2D6) using a series of molecular modeling methods. In this study, we further explored the binding modes of various types of inhibitors to CYP2D6 using a combination of ligand- and protein-based modeling approaches. Firstly, we developed and validated a pharmacophore model for CYP2D6 inhibitors, which consisted of two hydrophobic features and one hydrogen bond acceptor feature. Secondly, we constructed and validated a quantitative structure-activity relationship (QSAR) model for CYP2D6 inhibitors which gave a poor to moderate prediction accuracy. Thirdly, a panel of CYP2D6 inhibitors were subject to molecular docking into the active site of wild-type and mutated CYP2D6 enzyme. We demonstrated that 8 residues in the active site (Leu213, Glu216, Ser217, Gln244, Asp301, Ser304, Ala305, and Phe483) played an important role in the binding to the inhibitors via hydrogen bond formation and/or pi-pi stacking interaction. Apparent changes in the binding modes of the inhibitors have been observed with Phe120Ile, Glu216Asp, Asp301Glu mutations in CYP2D6. Finally, we screened for potential binders/inhibitors from the Chinese herbal medicine Scutellaria baicalensis (Huangqin, Baikal Skullcap) using the established pharmacophore model for CYP2D6 inhibitors and molecular docking approach. Overall, 18 out of 40 compounds from S. baicalensis were mapped to the pharmacophore model of CYP2D6 inhibitors and most herbal compounds from S. baicalensis could be docked into the active site of CYP2D6. Our study has provided insights into the molecular mechanisms of interaction of synthetic and herbal compounds with human CYP2D6 and further benchmarking studies are needed to validate our modeling and virtual screening results.
引用
收藏
页码:36 / 80
页数:45
相关论文
共 91 条
[1]
Allen SW, 2001, DRUG METAB DISPOS, V29, P1074
[2]
The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors [J].
Belpaire, FM ;
Wijnant, P ;
Temmerman, A ;
Rasmussen, BB ;
Brosen, K .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) :261-264
[3]
Black DJ, 1996, DRUG METAB DISPOS, V24, P422
[4]
Tamoxifen inhibits cytochrome P4502C9 activity in breast cancer patients [J].
Boruban, M. C. ;
Yasar, U. ;
Babaoglu, M. O. ;
Sencan, O. ;
Bozkurt, A. .
JOURNAL OF CHEMOTHERAPY, 2006, 18 (04) :421-424
[5]
Differential effects of nonhydroxylated flavonoids as inducers of cytochrome P450 1A and 2B isozymes in rat liver [J].
CanivencLavier, MC ;
Bentejac, M ;
Miller, ML ;
Leclerc, J ;
Siess, MH ;
Latruffe, N ;
Suschetet, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 136 (02) :348-353
[7]
Cytochrome P450 regulation: the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal [J].
Correia, Maria Almira ;
Sinclair, Peter R. ;
De Matteis, Francesco .
DRUG METABOLISM REVIEWS, 2011, 43 (01) :1-26
[8]
THE EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS ON CYTOCHROME-P4502D6 (CYP2D6) ACTIVITY IN HUMAN LIVER-MICROSOMES [J].
CREWE, HK ;
LENNARD, MS ;
TUCKER, GT ;
WOODS, FR ;
HADDOCK, RE .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (03) :262-265
[9]
Cytochrome P450 in silico: An integrative modeling approach [J].
de Graaf, C ;
Vermeulen, NPE ;
Feenstra, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (08) :2725-2755
[10]
In silico methods for predicting ligand binding determinants of cytochromes P450 [J].
de Groot, MJ ;
Kirton, SB ;
Sutcliffe, MJ .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (16) :1803-1824